← Human Trials & Peer-Reviewed Studies
Effects of Intranasal Oxytocin on Stress-Induced Cigarette Craving in Daily Smokers
Plain-language guide to PMID 30085292 (2020): double-blind randomized controlled trial study of Oxytocin.
Key Facts
- PMID
- 30085292
- Journal
- Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
- Year
- 2020
- Study type
- Randomized Controlled Trial
- Authors
- Van Hedger K et al. (4 authors)
- DOI
- 10.1093/ntr/nty159
What This Study Did, in Plain Language
What Was Tested
Researchers studied Oxytocin in this randomized controlled trial publication.
The purpose of the present study was to examine the effects of intranasal OT on stress-induced cigarette craving in regular smokers after 12 h of abstinence.
Why It Was Studied
One factor that is known to contribute to relapse is stress, making the stress response an important target for treatment.
Who Took Part
The age groups tagged for this paper are adults, both men and women.
Subjects were randomly assigned to one of three groups: Group PP (n = 16) received PBO before and after the stress/control tasks, Group OP (n = 16) received OT before the tasks and PBO after, and Group PO (n = 16) received PBO before the tasks and OT shortly after completing the tasks.
Cigarette craving as well as subjective and physiological responses to stress was assessed.
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
Random assignment meant chance, not the researchers, decided who got Oxytocin and who got the comparison, which limits bias.
As a double-blind Oxytocin study, the assignments were hidden from both participants and investigators until the end.
Some participants received a placebo instead of Oxytocin, giving a reference point.
What Was Measured
Topics PubMed links to this paper include Behavior, Addictive, Blood Pressure, Craving, Heart Rate, Oxytocics, Oxytocin and Smokers.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Oxytocin.
Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2020 (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco), a journal based in England.
More context: the Oxytocin compound page, all human trials.
Our Notes on the Compound
Oxytocin: A peptide hormone with established obstetric medical uses and a less settled role in research on behavior, sexual function and appetite.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.